양식용 사료 및 의약품 시장 : 세계 업계 분석, 규모, 점유율, 성장, 동향, 예측(2031년) - 제품 유형별, 종류별, 지역별
Aquaculture Feed and Pharmaceutical Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region:
상품코드:1420394
리서치사:Fairfield Market Research
발행일:2024년 01월
페이지 정보:영문 202 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 양식용 사료 및 의약품 시장 규모는 2024년에는 9억 9,940만 달러에 달할 것으로 보이고 있습니다. 이 제품에 대한 수요는 세계에서 안정되어 있으며, 연간 평균 성장률(CAGR)은 7.4%로 예측됩니다. 그 결과, 시장은 2031년말에는 20억 달러에 달할 전망입니다.
세계의 양식용 사료 및 의약품 시장은 의약품 및 생물학적 제제 분야의 지속적인 발전과 연구로 인해 2031년까지 크게 성장할 준비가 되어 있습니다. 최근 시장 분석에 따르면 의약품 및 생물학적 제제 부문은 금액과 성장 측면에서 이 산업의 지배적인 세력으로 부상할 것이며, 생물학적 제제 하위 부문은 예측 기간 중 7.7%의 놀라운 CAGR을 기록하며 다른 부문을 압도할 것으로 예상됩니다.
다양한 제품 유형 중 의약품 및 생물학적 제제 부문은 시장 매력도 지수가 1.6으로 가장 유리한 부문입니다. 반면, 약용 사료 부문은 시장 매력도 지수 0.4로 가장 매력적이지 않을 것으로 예상됩니다.
세계의 양식용 사료 및 의약품 시장에 대해 조사했으며, 시장의 개요와 제품 유형별, 종류별, 지역별 동향 및 시장에 참여하는 기업의 경쟁 동향 등을 제공하고 있습니다.
목차
제1장 주요 요약
제2장 시장 개요
시장의 정의와 세분화
시장 역학
밸류체인 분석
Porter's Five Forces 분석
COVID-19의 영향 분석
우크라이나와 러시아의 분쟁의 영향
경제 개요
PESTLE 분석
제3장 세계의 양식용 사료 및 의약품 시장 전망, 2018-2031년
세계의 양식용 사료 및 의약품 시장 전망, 제품 유형별, 금액(10억 달러), 2018-2031년
세계의 양식용 사료 및 의약품 시장 전망, 종류별, 금액(10억 달러), 2018-2031년
세계의 양식용 사료 및 의약품 시장 전망, 지역별, 금액(10억 달러), 2018-2031년
제4장 북미의 양식용 사료 및 의약품 시장 전망, 2018-2031년
제5장 유럽의 양식용 사료 및 의약품 시장 전망, 2018-2031년
제6장 아시아태평양의 양식용 사료 및 의약품 시장 전망, 2018-2031년
제7장 라틴아메리카의 양식용 사료 및 의약품 시장 전망, 2018-2031년
제8장 중동 및 아프리카의 양식용 사료 및 의약품 시장 전망, 2018-2031년
제9장 경쟁 구도
제품 유형별과 종류별 히트맵
기업의 시장 점유율 분석, 2023년
경쟁 대시보드
기업 개요
Zoetis, Inc.
Schouw & Co
Ridley Corporation Ltd
Merck & Co Inc
Biomin Holding GmbH
Aller Aqua A/S
Nutriad Ltd.
Alltech Inc.
Avanti Feeds Ltd.
Norel S.A.
Cargill, Incorporated
Beneo GmbH
Skretting AS
제10장 부록
KSA
영문 목차
영문목차
The global market size for aquaculture feed and pharmaceuticals is currently estimated to be at US$ 999.4 million in 2024. It is anticipated that there will be a steady demand for these products worldwide, with a projected Compound Annual Growth Rate (CAGR) of 7.4%. As a result, the market is expected to reach a valuation of US$ 2 billion by the conclusion of 2031.
The global aquaculture feed and pharmaceuticals market is poised for significant growth through 2031, driven by continuous advancements and research in the field of pharmaceuticals and biologics. A recent market analysis indicates that the pharmaceutical and biologics segment will emerge as the dominant force in this industry, both in terms of value and growth with the biologics sub-segment expected to outperform others, boasting an impressive 7.7% compound annual growth rate (CAGR) during the forecast period.
Most Lucrative Segment with Strong Market Attractiveness
Among various product types, the pharmaceutical and biologics segment is set to be the most lucrative, boasting a market attractiveness index of 1.6. In contrast, the medicated feed segment is expected to be the least attractive, with a market attractiveness index of 0.4.
Driving Factors Behind Market Growth
Several factors are fueling the growth of the pharmaceutical and biologics segment in the aquaculture feed and pharmaceuticals market. There is a growing demand for structured research and development in the aquaculture field, particularly in biologics research. This has led to a faster introduction of drugs, medicated feed, and vaccines into regional markets, particularly in developed countries such as the United States and Canada. Such initiatives have stimulated inorganic growth through strategic partnerships and M&A activities among key industry players.
Key Trends and Developments
In the United States, the use of extra label drugs in aquaculture, under the guidance of licensed veterinarians, has opened up opportunities for the development of medicated feed and pharmaceuticals. Regulatory bodies, such as the FDA, support the use of approved extra label aquaculture medicated feeds, provided they meet compliance conditions. This development is expected to expand the scope for further advancements in medicated feed and pharmaceuticals for aquaculture.
Furthermore, the demand for in-feed medication as a prophylactic measure is on the rise in the global aquaculture feed and pharmaceutical market. The adoption of in-feed medication to prevent the spread of diseases among healthy fish is growing, particularly in organized fishing farms across Europe. This trend aligns with the limited use of antibiotics in the region.
Governmental Collaborations Drive R&D
Governments in various countries are initiating collaborative research and development efforts in partnership with regulatory bodies to enhance the availability of high-quality medicated feed and pharmaceuticals for aquaculture. As aquaculture becomes a crucial source of food for human consumption, the need for safe and effective treatments for various fish diseases has grown significantly.
Challenges Ahead
Despite the growth prospects, the lack of harmonization of veterinary medicinal products and medicated feed regulations across different regions, particularly in the European Union, poses challenges. Different laws for manufacturing veterinary medicines and medicated feed, along with varying residue limits of veterinary medicines in feed, hinder market estimation and forecasting efforts.
Competitive Analysis:
Some of the prominent players in the global market for aquaculture feed & pharmaceutical market are:
Zoetis, Inc.
Schouw & Co
Ridley Corporation Ltd
Merck & Co Inc
Biomin Holding GmbH
Aller Aqua A/S
Nutriad Ltd.
Alltech Inc.
Avanti Feeds Ltd.
Norel S.A.
Cargill, Incorporated
Beneo GmbH
Skretting AS
Novus International Inc.
Growel Feeds Pvt. Ltd.
Neovia Vietnam
Evonik Industries AG
Bayer AG
Koninklijke DSM N.V
Others.
Market Segmentation
Product Type
Pharmaceutical and Biologics
Anti-infectives
Parasiticides
Biologics
Others
Medicated Feed
Vitamins and Minerals
Amino Acids
Acidifiers
Others
Species
Molluscs
Shrimp
Salmons
Carps
Tilapia
Catfish
Others
Region
North America
Latin America
Europe
Asia Pacific
Middle East and Africa (MEA)
Table of Contents
1. Executive Summary
1.1. Global Aquaculture Feed and Pharmaceutical Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Aquaculture Feed and Pharmaceutical Market Outlook, 2018 - 2031
3.1. Global Aquaculture Feed and Pharmaceutical Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Pharmaceutical and Biologics
3.1.1.1.1. Anti-infectives
3.1.1.1.2. Parasiticides
3.1.1.1.3. Biologics
3.1.1.1.4. Others
3.1.1.2. Medicated Feed
3.1.1.2.1. Vitamins and Minerals
3.1.1.2.2. Amino Acids
3.1.1.2.3. Acidifiers
3.1.1.2.4. Others
3.2. Global Aquaculture Feed and Pharmaceutical Market Outlook, by Species, Value (US$ Bn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Molluscs
3.2.1.2. Shrimp
3.2.1.3. Salmons
3.2.1.4. Carps
3.2.1.5. Tilapia
3.2.1.6. Catfish
3.2.1.7. Others
3.3. Global Aquaculture Feed and Pharmaceutical Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. North America
3.3.1.2. Europe
3.3.1.3. Asia Pacific
3.3.1.4. Latin America
3.3.1.5. Middle East & Africa
4. North America Aquaculture Feed and Pharmaceutical Market Outlook, 2018 - 2031
4.1. North America Aquaculture Feed and Pharmaceutical Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Pharmaceutical and Biologics
4.1.1.1.1. Anti-infectives
4.1.1.1.2. Parasiticides
4.1.1.1.3. Biologics
4.1.1.1.4. Others
4.1.1.2. Medicated Feed
4.1.1.2.1. Vitamins and Minerals
4.1.1.2.2. Amino Acids
4.1.1.2.3. Acidifiers
4.1.1.2.4. Others
4.2. North America Aquaculture Feed and Pharmaceutical Market Outlook, by Species, Value (US$ Bn), 2018 - 2031
